• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Virus-inspired drug delivery system travels cell to cell

December 1, 2016 By Sarah Faulkner

Virus-inspired drug delivery system travels cell to cellResearchers from the University of Utah and the University of Washington have developed self-assembling nanocages that are packaged within cell membranes and exported to travel from cell to cell, delivering therapeutics. The team’s work was published in Nature.

The drug delivery system is inspired by a mechanism used by viruses to spread their infectious materials among cells in a host’s body.”We’re shifting our perception from viruses as pathogens, to viruses as inspiration for new tools,” co-senior author Wesley Sundquist said in prepared remarks. Adding specific genetic code from viruses to the nanocages enabled them to undock from 1 cell, travel to another and dock there to empty its contents.

The team learned from viruses that their delivery system had to include an ability to grasp cell membranes, self-assemble and be released from cells. If any of these functions were neglected, the system didn’t work.

In this study, the nanocages encased materials that the researchers used to track the system as it moved. The next step is to design nanocages to deliver therapeutics, the team said. Changes can be made to the system, like swapping in a differently shaped cage.

The proof-of-concept study showed that the virus-inspired system works, but the team still needs to determine if the nanocages can last for long periods of time within living animals and if they can deliver drugs in therapeutic quantities.

“As long as we keep pushing knowledge forward we can guarantee there will be good outcomes, though we can’t guarantee what or when,” Sundquist said.

Filed Under: Drug-Device Combinations, Featured, Research & Development Tagged With: University of Utah, University of Washington

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS